共 26 条
[1]
Goldfracht I(2020)Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes Nat. Commun. 11 179-194 e174
[2]
Lee JH(2017)Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations Cell Stem Cell 21 223-230
[3]
Protze SI(2002)Tissue engineering of a differentiated cardiac muscle construct Circ. Res. 90 1518-1525
[4]
Laksman Z(2008)Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial Circulation 117 145-154
[5]
Backx PH(2013)The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation Cardiovasc Res. 98 2299-2306
[6]
Keller GM(2004)Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation Circulation 110 1879-1894
[7]
Zimmermann WH(2017)Modeling atrial fibrillation using human embryonic stem cell-derived atrial tissue Sci. Rep. 7 68-82
[8]
Roy D(2018)Human induced pluripotent stem cell-derived cardiac cell sheets expressing genetically encoded voltage indicator for pharmacological and arrhythmia studies Stem Cell Rep. 10 e006035-885
[9]
Wettwer E(2020)Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping Stem Cells Transl. Med. 10 862-243
[10]
Wettwer E(2018)Human induced pluripotent stem cell-derived engineered heart tissue as a sensitive test system for QT prolongation and arrhythmic triggers Circ. Arrhythm. Electrophysiol. 11 239-745